About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
ADMS - Adamas Pharmaceutica...| Previous Close | $4.75 | Open | $4.73 |
| Volume | 847.5K | Market Cap | 126.93M |
| Yield | Last Dividend |
| Adamas Pharmaceuticals Announces Pricing... | 02/24/21 |
| EMERYVILLE, Calif.--(BUSINESS WIRE)--Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make... | |
| Adamas Pharmaceuticals (NASDAQ:ADMS) Iss... | 02/24/21 |
| Adamas Pharmaceuticals (NASDAQ:ADMS) posted its earnings results on Monday. The specialty pharmaceutical company reported ($0.64) earnings per share f... | |
| Adamas Pharmaceuticals Announces Launch ... | 02/24/21 |
| EMERYVILLE, Calif.--(BUSINESS WIRE)--Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make... | |
| Adamas Reports Fourth Quarter and Full Y... | 02/23/21 |
| EMERYVILLE, Calif.--(BUSINESS WIRE)--Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make... | |
| The Week Ahead In Biotech: J&J Vaccine A... | 02/20/21 |
| Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before picking up pa... | |
| Adamas to Present at Upcoming Healthcare... | 02/17/21 |
| EMERYVILLE, Calif.--(BUSINESS WIRE)--Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make... | |
| Adamas to Announce Fourth Quarter and Ye... | 02/10/21 |
| EMERYVILLE, Calif.--(BUSINESS WIRE)--Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the company will report fourth quarter and year-... | |
| Adamas Pharmaceuticals, Inc. (NASDAQ:ADM... | 02/03/21 |
| Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) insider Vijay Shreedhar sold 4,514 shares of the business???s stock in a transaction that occurred on Monda... | |
| Adamas Pharmaceuticals, Inc. (NASDAQ:ADM... | 02/02/21 |
| Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) CFO Christopher B. Prentiss sold 3,821 shares of the stock in a transaction dated Monday, February 1st. The... | |
| Adamas Announces FDA Approval for Second... | 02/01/21 |
| Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people af | |
| Adamas Announces Settlement of Patent Li... | 02/01/21 |
| EMERYVILLE, Calif.--(BUSINESS WIRE)--Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make... | |
| Attention Biotech Investors: Mark Your C... | 01/31/21 |
| Coming off a stellar year, when a record 53 new molecular entities were approved, 2021 has a lot to live up to. NMEs are a measure of innovation among... | |
| Adamas to Present at Upcoming ICR Confer... | 01/07/21 |
| EMERYVILLE, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering??? | |
| Adamas to Present at Upcoming H.C. Wainw... | 01/04/21 |
| EMERYVILLE, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering??? | |
| Adamas Announces New Employment Induceme... | 12/11/20 |
| EMERYVILLE, Calif., Dec. 11, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of t... | |
| Adamas announces changes to its Board of... | 11/23/20 |
| EMERYVILLE, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) a company dedicated to developing and delivering??? | |
| Adamas announces settlement agreement of... | 11/02/20 |
| EMERYVILLE, Calif., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering??? | |
| Adamas Pharmaceuticals (NASDAQ:ADMS) Rai... | 10/22/20 |
| Zacks Investment Research upgraded shares of Adamas Pharmaceuticals (NASDAQ:ADMS) from a sell rating to a hold rating in a research report released on... | |
| Adamas Pharmaceuticals (NASDAQ:ADMS) Upg... | 10/21/20 |
| Zacks Investment Research upgraded shares of Adamas Pharmaceuticals (NASDAQ:ADMS) from a sell rating to a hold rating in a research note released on M... | |
| Brokerages Set Adamas Pharmaceuticals In... | 10/21/20 |
| Shares of Adamas Pharmaceuticals Inc (NASDAQ:ADMS) have been assigned a consensus rating of ???Buy??? from the nine research firms that are presently ... | |
| Zacks Investment Research Upgrades Adama... | 10/21/20 |
| Adamas Pharmaceuticals (NASDAQ:ADMS) was upgraded by Zacks Investment Research from a ???sell??? rating to a ???hold??? rating in a research note issu... | |
| Adamas Pharmaceuticals (NASDAQ:ADMS) Sha... | 10/20/20 |
| Shares of Adamas Pharmaceuticals Inc (NASDAQ:ADMS) fell 8.7% on Tuesday . The stock traded as low as $3.82 and last traded at $3.90. 510,174 shares tr... | |
| The Daily Biotech Pulse: Adamas Rallies ... | 06/05/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 4) Bioh... | |
| All You Need to Know About Adamas (ADMS)... | 04/28/20 |
| Adamas (ADMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). | |
| The Daily Biotech Pulse: Pfizer's Eczema... | 03/19/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 18)... | |
| The Daily Biotech Pulse: Roche Obtains F... | 03/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) ... | |
| The Daily Biotech Pulse: NY State Endors... | 03/11/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10)... | |
| The Daily Biotech Pulse: Mesoblast To Te... | 03/10/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) A... | |
| Adamas Pharma EPS misses by $0.02, beats... | 02/25/20 |
| Adamas Pharma (NASDAQ:ADMS): Q4 GAAP EPS of -$0.83 misses by $0.02. Revenue of $16.35M (+22.7% Y/Y) beats by $0.09M. Shares +1.7%. Press Release | |
| ALERT: ROSEN, NATIONAL INVESTOR COUNSEL,... | 02/05/20 |
| NEW YORK, Feb. 5, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Adamas Pharmaceutica... | |
| Date | 2021-02-23 (AMC) | Est. (EPS/Rev.) | ($0.51)/ 20.96M |
| Actual (EPS/Rev.) | $-0.64/ $21.01 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Alpha Swing Trades | Jonathan | 68.00 % | Follow |
| Biotechnology | Robert Gadimian | 26.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
